Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);Application
Figure 2:Western blot analysis using FOXM1 mAb against human FOXM1 (AA: 649-748) recombinant protein. (Expected MW is 36.6 kDa)Application
Figure 3:Western blot analysis using FOXM1 mAb against HEK293 (1) and FOXM1 (AA: 649-748)-hIgGFc transfected HEK293 (2) cell lysate.Application
Figure 4:Flow cytometric analysis of HeLa cells using FOXM1 mouse mAb (green) and negative control (red).| Product Name | FOXM1 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MPP2; TGT3; HFH11; HNF-3; INS-1; MPP-2; PIG29; FKHL16; FOXM1B; HFH-11; TRIDENT; MPHOSPH2 |
| Immunogen | Purified recombinant fragment of human FOXM1 (AA: 649-748) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBFCMICC/IF |
| WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | MPP2 TGT3 HFH11 HNF-3 INS-1 MPP-2 PIG29 FKHL16 FOXM1B HFH-11 TRIDENT MPHOSPH2 |
|---|---|
| Molecular Weight(MW) | 84.3kDa |
| Entrez Gene | 2305 |
|---|
Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Application
Figure 2:Western blot analysis using FOXM1 mAb against human FOXM1 (AA: 649-748) recombinant protein. (Expected MW is 36.6 kDa)
Application
Figure 3:Western blot analysis using FOXM1 mAb against HEK293 (1) and FOXM1 (AA: 649-748)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Flow cytometric analysis of HeLa cells using FOXM1 mouse mAb (green) and negative control (red).| Application Notes | WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
